TROP2 overexpression promotes proliferation and invasion of lung adenocarcinoma cells

Biochemical and Biophysical Research Communications

Volumn 470, Issue 1, 2016, Pages 197-204

  Li, Zanhua ^a,b   Jiang, Xunsheng ^a   Zhang, Wei ^a  

^a NANCHANG UNIVERSITY   (China)

^b Chest Hospital of Jiangxi Province   (China)

Author keywords

Apoptosis; Invasion; Lung adenocarcinoma; Migration; Proliferation; TROP2

Indexed keywords

GLYCOPROTEIN; TROPHOBLAST CELL SURFACE ANTIGEN 2; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; TACSTD2 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

A549 CELL LINE; ADENOCARCINOMA CELL LINE; ADULT; APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG PARENCHYMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; ADENOCARCINOMA; AGED; CHINA; EPIDEMIOLOGY; LUNG TUMOR; METABOLISM; MORTALITY; PATHOLOGY; PREVALENCE; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TUMOR CELL LINE; TUMOR INVASION; UPREGULATION;

ADENOCARCINOMA; ADULT; AGED; ANTIGENS, NEOPLASM; BIOMARKERS, TUMOR; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL PROLIFERATION; CHINA; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM INVASIVENESS; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; UP-REGULATION;

EID: 84956837909     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.01.032     Document Type: Article

References (28)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int. J. Cancer 127 2010 2893 2917
2. Y. Qu, X. Wu, Y. Yin, Y. Yang, D. Ma, and H. Li Antitumor activity of selective MEK1/2 inhibitor AZD6244 in combination with PI3K/mTOR inhibitor BEZ235 in gefitinib-resistant NSCLC xenograft models J. Exp. Clin. Cancer Res. 33 2014 52
3. M. Tsuboi, T. Ohira, H. Saji, K. Miyajima, N. Kajiwara, O. Uchida, J. Usuda, and H. Kato The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer Ann. Thorac. Cardiovasc Surg. 13 2007 73 77
4. J. Wang, Q. Shen, Q. Shi, B. Yu, X. Wang, K. Cheng, G. Lu, and X. Zhou Detection of ALK protein expression in lung squamous cell carcinomas by immunohistochemistry J. Exp. Clin. Cancer Res. 33 2014 109
5. X. Chen, X. Guan, H. Zhang, X. Xie, H. Wang, J. Long, T. Cai, S. Li, Z. Liu, and Y. Zhang DAL-1 attenuates epithelial-to mesenchymal transition in lung cancer J. Exp. Clin. Cancer Res. 34 2015 3
6. G. Lin, L. Sun, R. Wang, Y. Guo, and C. Xie Overexpression of muscarinic receptor 3 promotes metastasis and predicts poor prognosis in non-small-cell lung cancer J. Thorac. Oncol. 9 2014 170 178
7. G. Chen, and X.H. Yi Pathology and genetics of disease and tumours of the lung, pleura in China Zhonghua Bing Li Xue Za Zhi 34 2005 490 493
8. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J. Clin. 59 2009 225 249
9. K.W. Jung, S. Park, H.J. Kong, Y.J. Won, J.Y. Lee, H.G. Seo, and J.S. Lee Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009 Cancer Res. Treat. 44 2012 11 24
10. E. Ripani, A. Sacchetti, D. Corda, and S. Alberti Human Trop-2 is a tumor-associated calcium signal transducer Int. J. Cancer 76 1998 671 676
11. G. Mangino, M. Grazia Capri, V. Barnaba, and S. Alberti Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells Int. J. Cancer 101 2002 353 359
12. R.M. Sharkey, W.J. McBride, T.M. Cardillo, S.V. Govindan, Y. Wang, E.A. Rossi, C.H. Chang, and D.M. Goldenberg Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2-SN-38 Antibody Conjugate (Sacituzumab Govitecan) Clin. Cancer Res. 21 2015 5131 5138
13. D. Fong, P. Moser, C. Krammel, J.M. Gostner, R. Margreiter, M. Mitterer, G. Gastl, and G. Spizzo High expression of TROP2 correlates with poor prognosis in pancreatic cancer Br. J. Cancer 99 2008 1290 1295
14. G. Muhlmann, G. Spizzo, J. Gostner, M. Zitt, H. Maier, P. Moser, G. Gastl, M. Zitt, H.M. Muller, R. Margreiter, D. Ofner, and D. Fong TROP2 expression as prognostic marker for gastric carcinoma J. Clin. Pathol. 62 2009 152 158
15. D. Fong, G. Spizzo, J.M. Gostner, G. Gastl, P. Moser, C. Krammel, S. Gerhard, M. Rasse, and K. Laimer TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity Mod. Pathol. 21 2008 186 191
16. M.G. Pak, D.H. Shin, C.H. Lee, and M.K. Lee Significance of EpCAM and TROP2 expression in non-small cell lung cancer World J. Surg. Oncol. 10 2012 53
17. Y.J. Fang, G.Q. Wang, Z.H. Lu, L. Zhang, J.B. Li, X.J. Wu, P.R. Ding, Q.J. Ou, M.F. Zhang, W. Jiang, Z.Z. Pan, and D.S. Wan Different effects of ERbeta and TROP2 expression in Chinese patients with early-stage colon cancer Tumour Biol. 33 2012 2227 2235
18. H. Wu, H. Xu, S. Zhang, X. Wang, H. Zhu, H. Zhang, J. Zhu, and J. Huang Potential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma Head. Neck 35 2013 1373 1378
19. Y.J. Fang, Z.H. Lu, G.Q. Wang, Z.Z. Pan, Z.W. Zhou, J.P. Yun, M.F. Zhang, and D.S. Wan Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer Int. J. Colorectal Dis. 24 2009 875 884
20. L.P. Stepan, E.S. Trueblood, K. Hale, J. Babcook, L. Borges, and C.L. Sutherland Expression of Trop2 cell surface glycoprotein in normal and tumor tissues: potential implications as a cancer therapeutic target J. Histochem Cytochem 59 2011 701 710
21. T. Stoyanova, A.S. Goldstein, H. Cai, J.M. Drake, J. Huang, and O.N. Witte Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via beta-catenin signaling Genes Dev. 26 2012 2271 2285
22. T. El Sewedy, M. Fornaro, and S. Alberti Cloning of the murine TROP2 gene: conservation of a PIP2-binding sequence in the cytoplasmic domain of TROP-2 Int. J. Cancer 75 1998 324 330
23. J. Lu, K.I. Izvolsky, J. Qian, and W.V. Cardoso Identification of FGF10 targets in the embryonic lung epithelium during bud morphogenesis J. Biol. Chem. 280 2005 4834 4841
24. E. Bignotti, P. Todeschini, S. Calza, M. Falchetti, M. Ravanini, R.A. Tassi, A. Ravaggi, E. Bandiera, C. Romani, L. Zanotti, G. Tognon, F.E. Odicino, F. Facchetti, S. Pecorelli, and A.D. Santin Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients Eur. J. Cancer 46 2010 944 953
25. J. Wang, R. Day, Y. Dong, S.J. Weintraub, and L. Michel Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers Mol. Cancer Ther. 7 2008 280 285
26. J. Varughese, E. Cocco, S. Bellone, M. Bellone, P. Todeschini, L. Carrara, P.E. Schwartz, T.J. Rutherford, S. Pecorelli, and A.D. Santin High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody Gynecol. Oncol. 122 2011 171 177
27. N.L. Solimini, J. Luo, and S.J. Elledge Non-oncogene addiction and the stress phenotype of cancer cells Cell 130 2007 986 988
28. H. Lin, J.F. Huang, J.R. Qiu, H.L. Zhang, X.J. Tang, H. Li, C.J. Wang, Z.C. Wang, Z.Q. Feng, and J. Zhu Significantly upregulated TACSTD2 and Cyclin D1 correlate with poor prognosis of invasive ductal breast cancer Exp. Mol. Pathol. 94 2013 73 78